Diamonds and Dogs


Biotech performing well. Karuna Therapeutics (KRTX) is up 32% today and is up six-fold in the last week with a market cap of nearly $3 billion on positive news of their phase 2 trial of its schizophrenia treatment. The treatment of acute psychosis in schizophrenia patients demonstrated a "statistically significant and clinically meaningful" reduction in total positive and negative syndrome scale (PANSS) score compared with a placebo. The stock came public in June so its safe to say it's the best IPO stock for the year.

A tough day for retail. Kohl's (KSS) is down 17% not far from a 52-week low following disappointing earnings and lower guidance for 2020. The company is blaming cooler and wet weather on the spring, but that can't be the reason for lower guidance. The company has been banking on increased consumer foot traffic from a nationwide expansion of a program that allows customers to use Kohl's stores to return some products bought on Amazon. Not happening. The stock is down 30% since the new CEO took over in May. She gets paid $12 million for losing money for shareholders. Home Depot (HD) is down 4% on disappointing earnings and lower guidance. Macy's (M) is down 9% on news of a data breach.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.